Using CRISPR/Tuba-seq, a study of 48 TSGs characterizes the functional landscape of tumor suppression in an KRAS-driven lung cancer model, revealing novel genetics of KRAS-driven lung cancer initiation, overall and abnormal growth (Cai et al., 2021). The gene discussed is KRAS; the disease is neoplasm.